Topic resource collection
Approved comparison material connected to this topic.
774 resourcesRead both sides
BPC-157 Anti-inflammatory, angiogenic NF-κB inhibition, VEGF upregulation 60% reduction in serum ALT, 40% reduction in steatosis score (Journal of Physiology Paris) Lyophilized at -20°C; reconstituted at 2–8°C, use within 14 days…
GHK-Cu (Copper Peptide) TGF- downregulation, VEGF upregulation, collagen synthesis in dermal papilla 340 Da Topical (penetrates intact skin) 18% hair count increase at 12 weeks (Journal of Drugs in Dermatology, 2015) Strongest cl…
MC1R Selectivity High (13x selective for MC1R) Low (non-selective across MC1R, MC3R, MC4R, MC5R) MT-I produces pigmentation with fewer systemic side effects but requires higher cumulative dose Pigmentation Speed Moderate (2–3 wee…
Thymalin Thymic immune modulation. Normalizes T-cell function, reduces IL-6 and TNF-alpha Chronic inflammation reduction, endothelial protection 10–20 mg subcutaneous 2–3x weekly Targets downstream inflammation. Doesn't address a…
Thymalin T-regulatory cell restoration; reduces mast cell hypersensitivity through immune recalibration 3–6 weeks for sustained effect 10mg SC twice weekly × 8 weeks Phase 2 clinical data in MCAS populations Best for systemic imm…
CJC-1295 / Ipamorelin GHRH + ghrelin mimetic. Stimulates GH release, which upregulates LH and testosterone synthesis CJC: 500 mcg 2×/week; Ipamorelin: 200–300 mcg daily before bed 6–10 weeks for measurable testosterone increase Y…
Cerebrolysin Neurotrophic factor delivery (BDNF, NGF, CNTF) Restores prefrontal BDNF deficits; enhances synaptic plasticity for habit remodeling 10–30mL IV infusion, 10–20 sessions over 4–8 weeks 4–6 hours; IV only Most evidence …
| Peptide | Primary Mechanism | Panic-Relevant Action | Human Trial Evidence | Typical Research Dose | Administration Route | Professional Assessment ||—|—|—|—|—|—|| BPC-157 | Gastric protection, unclear CNS pathway | Normalizes …
BPC-157 VEGF upregulation, angiogenesis, collagen type I deposition Rodent tendon models show 30–40% faster repair; no large human trials 250–500 mcg daily SubQ Best for soft tissue microtears in ligaments and fascia where angiog…
BPC-157 VEGF upregulation, angiogenesis promotion, fibroblast activation 250–500mcg daily subcutaneous VEGFR-2, nitric oxide synthase, collagen synthesis 8–12 weeks for measurable strength improvement First-line choice for chroni…
BPC-157 Promotes angiogenesis, upregulates VEGF and bFGF, accelerates mucosal healing 250–500mcg daily Once daily ~4 hours (requires daily dosing) Most evidence for direct GI tissue repair; studied extensively in colitis models T…
Before selecting a peptide, understand how each compound differs in mechanism, target tissue, administration route, and evidence base. BPC-157 VEGF upregulation, angiogenesis, nitric oxide stabilization Mucosal injury, IBD, NSAID…
BPC-157 VEGF upregulation, angiogenesis 250–500mcg Twice daily Tendons, ligaments, gastric tissue 2–8°C, 28 days max Gold standard for localized soft tissue repair. Fastest results in tendon injuries TB-500 Actin regulation, cell…
Mechanism Upregulates VEGF and growth hormone receptors; enhances fibroblast migration to injury site Promotes actin polymerisation and angiogenesis; reduces inflammation via downregulation of pro-inflammatory cytokines Complemen…
BPC-157 VEGF upregulation, collagen synthesis, tight junction protein expression (occludin, claudin) 500–1000 mcg daily (split into 2 doses) 4–6 hours Subcutaneous (lower abdomen preferred) Gold standard for structural gut repair…
Before selecting peptides for rotator cuff research, compare their mechanisms, dosing complexity, and storage requirements. This table summarises the three categories most relevant to tendon healing models. BPC-157 Upregulates VE…
Cerebrolysin BDNF upregulation, synaptic plasticity enhancement Inattentive-type: working memory deficits, sustained attention 2–3 times per week, 5–10 mL per dose Most evidence-backed for cognitive enhancement; requires IM injec…
MOTS-c Mitochondrial biogenesis via AMPK activation Increased oxidative capacity and fatty acid metabolism 30% improvement in time to exhaustion (mouse model) 5–15mg SC 2–3×/week Well-tolerated in animal studies; human safety dat…
Selank Enkephalin modulation + HPA axis regulation Anxious depression, high cortisol 300–600mcg intranasal 2x/day, 14–28 days Moderate (3 RCTs, n=247) First-line for anxiety-driven depression; fast onset, minimal sides Cerebrolys…
Before starting any peptide regimen, understand that different compounds require different administration strategies based on half-life, receptor dynamics, and stacking compatibility. CJC-1295 (no DAC) GH-releasing hormone analog…